Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of elderly and unfit patients with chronic lymphocytic leukemia.
Mauro FR, Salaroli A, Caputo MD, Colafigli G, Petrucci L, Campanelli M, Ferretti A, Guarini AR, Foà R. Mauro FR, et al. Among authors: salaroli a. Expert Rev Hematol. 2016 Dec;9(12):1165-1175. doi: 10.1080/17474086.2016.1254544. Epub 2016 Nov 21. Expert Rev Hematol. 2016. PMID: 27796157 Review.
Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.
Capria S, Barberi W, Perrone S, Ferretti A, Salaroli A, Annechini G, D'Elia GM, Foà R, Pulsoni A. Capria S, et al. Among authors: salaroli a. Expert Rev Hematol. 2016 Oct;9(10):951-64. doi: 10.1080/17474086.2016.1226128. Epub 2016 Aug 31. Expert Rev Hematol. 2016. PMID: 27539362 Review.
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.
Mauro FR, Morabito F, Vincelli ID, Petrucci L, Campanelli M, Salaroli A, Uccello G, Petrungaro A, Ronco F, Raponi S, Nanni M, Neri A, Ferrarini M, Guarini AR, Foà R, Gentile M. Mauro FR, et al. Among authors: salaroli a. Leuk Res. 2017 Jun;57:65-71. doi: 10.1016/j.leukres.2017.02.011. Epub 2017 Feb 27. Leuk Res. 2017. PMID: 28292720
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
Chisini M, Stefanizzi C, Ceglie T, Raponi S, Vozella F, Colafigli G, Salaroli A, D'Angiò M, Mancini M, Diverio D, Breccia M, Mancini F, Minotti C, Trisolini S, Capria S, Testi AM, Guarini A, Latagliata R, De Propris MS, Foà R. Chisini M, et al. Among authors: salaroli a. Hematol Oncol. 2017 Dec;35(4):804-809. doi: 10.1002/hon.2331. Epub 2016 Jul 12. Hematol Oncol. 2017. PMID: 27400753
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response.
Latagliata R, Romano A, Mancini M, Breccia M, Carmosino I, Vozella F, Montagna C, Volpicelli P, De Angelis F, Petrucci L, Serrao A, Molica M, Salaroli A, Diverio D, Alimena G. Latagliata R, et al. Among authors: salaroli a. Leuk Lymphoma. 2016;57(1):99-102. doi: 10.3109/10428194.2015.1043548. Epub 2015 Oct 5. Leuk Lymphoma. 2016. PMID: 25997497
Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase.
Breccia M, Girmenia C, Latagliata R, Loglisci G, Santopietro M, Federico V, Petrucci L, Serrao A, Salaroli A, Alimena G. Breccia M, et al. Among authors: salaroli a. Mediterr J Hematol Infect Dis. 2011;3(1):e2011021. doi: 10.4084/MJHID.2011.021. Epub 2011 May 16. Mediterr J Hematol Infect Dis. 2011. PMID: 21713076 Free PMC article.
54 results